Towards Healthcare
North America Central Lab Market to Reach USD 2411 Mn by 2034

North America Central Lab Market Rising Clinical Trials and AI Integration

Projections indicate that, North America central lab industry is projected to rise from USD 1384 million in 2024 to USD 2411 million by 2034, reflecting a CAGR of 5.71% over the next decade. The presence of a favorable clinical trial infrastructure and regulatory support drives the market. The dominance of the U.S. is attributed to the presence of key players and the increasing investments.

  • Insight Code: 6299
  • No. of Pages: 150+
  • Format: PDF/PPT/Excel
  • Published: October 2025
  • Report Covered: [Revenue + Volume]
  • Historical Year: 2021-2022
  • Base Year: 2023
  • Estimated Years: 2024-2033

About The Author

Rohan Patil is a seasoned market research professional with over 5 years of focused experience in the healthcare sector, bringing deep domain expertise, strategic foresight, and analytical precision to every project he undertakes.

He began his journey with Precedence Research, where he played a pivotal role in developing high-impact healthcare market reports. Today, Rohan leads research initiatives at Towards Healthcare, while also contributing to Statifacts, where he supports cross-industry analysis and data-driven storytelling.

Rohan’s core strengths lie in trend analysis and emerging technologies, regulatory monitoring and thought leadership through high-quality report writing. He excels at identifying future-ready opportunities and translating complex data into strategic recommendations. His work spans pharmaceuticals, biotechnology, medical devices, and digital health, assessing everything from market potential and competitive positioning to customer needs and regulatory shifts.

A trusted advisor and a relentless innovator, Rohan continues to push the boundaries of traditional market research, merging scientific rigor with commercial insight to stay ahead in a fast-evolving healthcare landscape.

FAQ's

The North America central lab market in 2025 is valued at USD 1463 million and is projected to climb to USD 2411 million by 2034, with a CAGR of 5.71% over the forecast period.

The U.S. is leading the North America central lab market due to the availability of robust clinical trial infrastructure and technological advancements.

Some key players include IQVIA, PPD, CIRION, and GBA Group.

Central labs implement rigorous quality control procedures and undergo regular external accreditation and regulatory compliance assessments.

Food and Drug Administration, Government of Canada, National Institute of Health, clinicaltrials.gov